Author Archives: admin

The NIH has turned into a source of welfare for bloated universities

September 12, 2017- Science reports, “President Donald Trump’s administration has brought a long-simmering debate over how the U.S. government supports university research

Posted in - Opinion, Congress, NIH | 1 Comment

Is Vitamin-D deficiency overdiagnosed?

November 8, 2016- Interviewed by Steven E. Greer, MD We interviewed JoAnn E. Manson, MD, DrPH, Chief, Division of Preventive Medicine,  Brigham

Posted in - NEJM, - Policy, CDC, Diabetes and endocrinology, FDA, Harvard, Primary care medicine | Leave a comment

The Weekly Summary

November 3rd – November 12th                                 2017 In general news, Saudi Arabia’s leader rounded up a dozen or more billionaire princes viewed to be corrupt in an effort to emulate the oligarch dictators of China and Russia who have

Posted in - The Weekly Summary | Leave a comment

The Daltrey Townshend teenage and young adult cancer center at UCLA

May 4, 2014- Interviewed by Steven E. Greer More than 20 years ago, Roger Daltrey began forming special cancer units in the UK to treat patients in their teenage

Posted in - Opinion, Oncology, Rehab, UCLA | Leave a comment

Ocrelizumab (Ocrevus) versus Placebo in Primary Progressive Multiple Sclerosis

January 31, 2017- Interviewed by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Pharma, Neurology, Univ Texas | 1 Comment

Aerobic or Resistance Exercise, or Both, in Dieting Obese Older Adults

June 14, 2017- Interviewed by Steven E. Greer, MD We interviewed Dennis Villareal, MD, the author of the NEJM paper “Aerobic or Resistance

Posted in - NEJM, Bariatric surgery, Baylor, Diabetes and endocrinology, Geriatrics, Internal Medicine | Leave a comment

An emerging safety problem for TAVR patients

March 16, 2017- produced and interviewed by Steven E. Greer, MD We interviewed William O’Neill, MD, one of the first to implant a Transcatheter Aortic Valve Replacement (TAVR) valve. The products have been approved by the FDA for several years, … Continue reading

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA | Leave a comment

Review: Walk-in urgent care centers are the way to go

January 6, 2015- by Steven E. Greer, MD A patient asked for my help yesterday with a sinus infection that was lingering. I referred him to

Posted in - Opinion, - Policy, - Reviews, books, devices, CMS, Emergency medicine, Pediatrics, Primary care medicine | Leave a comment

The egregious athletic coaching most kids receive

March 25, 2016- by Steven E. Greer, MD In 2005, at age 37, I got some good PGA golf lessons at Muirfield Golf Club in Ohio: Jack Nicklaus’

Posted in - Opinion, - Reviews, books, devices, Ohio State, Ohio State, Sports medicine | Leave a comment

Interview with the CEO of Galena Biopharma about cancer vaccines

February 8, 2016- Interviewed by Steven E. Greer, MD

Posted in - Biotech, Oncology | Leave a comment

The Weekly Summary

October 30th – November 2nd                                 2017 In general news, an ISIS-inspired man driving a rental truck mowed over dozens of people

Posted in - The Weekly Summary | Leave a comment

Early stoppage of clinical trials

April 16, 2009– Dr. Guyatt explained in a previous post why early stoppage of clinical trials results

Posted in Cardiac surgery, FDA, McMaster University | Leave a comment

What 1982’s Blade Runner got right about 2019

September 3, 2017- by Steven E. Greer, MD I watched again the 1982 classic Blade Runner. Directed by Ridley Scott and starring Harrison Ford,

Posted in - Opinion, - Reviews, books, devices, Genetics, Geriatrics, Obstetrics and Gynecology, Oncology, Ophthalmology | Leave a comment

The Weekly Summary

October 23rd – October 29th                                 2017  In general news, per a 1992 law, the secret FBI and CIA files on the assignation of President

Posted in - The Weekly Summary | Leave a comment

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

February 27, 2017- interviewed by Steven E. Greer, MD We interviewed Joaquim Bellmunt, MD, PhD, the Director of the Bladder Cancer Center at Dana-Farber,

Posted in - Biotech, - NEJM, - Pharma, Harvard, Oncology | Leave a comment

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

May 23, 2017- interviewed by Steven E. Greer, MD We interviewed polumonologist Michael Wechsler, MD about his paper in the NEJM testing mepolizumab

Posted in - NEJM, National Jewish Health, Pulmonology, Rheumatology | Leave a comment

The 23andMe home genetics test kit controversy

December 19, 2013- Interviewed by Steven E. Greer,  MD

Posted in Columbia, FDA, Genetics, NIH, Oncology, Psychology Psychiatry | Leave a comment

KIT inhibition by Gleevec (imatinib) for severe asthma

May 26, 2017- Interviewed by Steven E. Greer, MD Novartis’ Gleevec (imatinib) was approved in the U.S. in 2001 to treat leukemia. Now, researchers

Posted in - Biotech, - NEJM, - Pharma, National Jewish Health, Pulmonology | Leave a comment

Trump made a big mistake wading into the quagmire of healthcare

Is President Obama foreseeing the future here and having a laugh? May 7, 2017- Opinion by Steven E. Greer, MD I watched Face the Nation and the news coverage of Friday town hall meetings. Mick Mulvaney was

Posted in - Opinion, CMS, Congress | Leave a comment

Insurance companies are not paying for Repatha and Praluent

March 8, 2017- Interviewed by Steven E. Greer, MD We interviewed cardiologist William O’Neill, MD about his personal need for the cholesterol-lowering, large-molecule, antibody drug from Amgen, branded as Repatha. Despite

Posted in - Biotech, - Pharma, - Policy, Cardiac surgery, Cardiology, Henry Ford, Primary care medicine | 1 Comment